000			02112 a2200661 4500
005			20250517073203.0
264		0	_c20161027
008			201610s 0 0 eng d
022			_a1476-5608
024	7		_a10.1038/pcan.2015.59 _2doi
040			_aNLM _beng _cNLM
100	1		_aArmstrong, A J
245	0	0	_aA phase 2 multimodality trial of docetaxel/prednisone with sunitinib followed by salvage radiation therapy in men with PSA recurrent prostate cancer after radical prostatectomy. _h[electronic resource]
260			_bProstate cancer and prostatic diseases _cMar 2016
300			_a100-6 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aDisease-Free Survival
650	0	4	_aDocetaxel
650	0	4	_aHumans
650	0	4	_aIndoles _xadministration & dosage
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Grading
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aProstate-Specific Antigen _xmetabolism
650	0	4	_aProstatectomy
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aPyrroles _xadministration & dosage
650	0	4	_aQuality of Life
650	0	4	_aSalvage Therapy
650	0	4	_aSunitinib
650	0	4	_aTaxoids _xadministration & dosage
700	1		_aHalabi, S
700	1		_aHealy, P
700	1		_aLee, W R
700	1		_aKoontz, B F
700	1		_aMoul, J W
700	1		_aMundy, K
700	1		_aCreel, P
700	1		_aWood, S
700	1		_aDavis, K
700	1		_aCarducci, M A
700	1		_aStein, M
700	1		_aHobbs, C
700	1		_aReimer, B
700	1		_aNguyen, M
700	1		_aAnand, M
700	1		_aBratt, L
700	1		_aKim, S
700	1		_aTran, P T
700	1		_aGeorge, D J
773	0		_tProstate cancer and prostatic diseases _gvol. 19 _gno. 1 _gp. 100-6
856	4	0	_uhttps://doi.org/10.1038/pcan.2015.59 _zAvailable from publisher's website
999			_c25619674 _d25619674